PASADENA, Calif.--(BUSINESS WIRE)--Holoclara, a biotechnology company pioneering the development of worm-derived therapies for allergic and autoimmune disorders, today announced the launch of a ...
Financing led by BOLD Capital Partners, alongside early investments from Horizons Ventures and participation from a syndicate of leading angel investors in the life sciences Capital to support ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results